Crosstalk between the NF-κB activating IKK-complex and the CSN signalosome

Journal of Cellular and Molecular Medicine

Volumn 14, Issue 6 B, 2010, Pages 1555-1568

  Orel, Lukas ^a   Neumeier, Hannah ^b   Hochrainer, Karin ^c   Binder, Bernd R ^a   Schmid, Johannes A ^a  

^a MEDICAL UNIVERSITY OF VIENNA   (Austria)

^b INSTITUTE OF MOLECULAR BIOTECHNOLOGY   (Austria)

^c WEILL CORNELL MEDICAL COLLEGE   (United States)

Author keywords

CSN complex; I B kinase; Inflammation; JAB1; NF B; Protein interactions; Ubiquitination

Indexed keywords

COP9 SIGNALOSOME; COPS5 PROTEIN, HUMAN; I KAPPA B KINASE; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; MULTIPROTEIN COMPLEX; PEPTIDE HYDROLASE; SIGNAL PEPTIDE;

APOPTOSIS; ARTICLE; CELL LINE; FLUORESCENCE RESONANCE ENERGY TRANSFER; HUMAN; METABOLISM; PHOSPHORYLATION; PROTEIN BINDING; PROTEIN PROCESSING; SIGNAL TRANSDUCTION; UBIQUITINATION;

APOPTOSIS; CELL LINE; FLUORESCENCE RESONANCE ENERGY TRANSFER; HUMANS; I-KAPPA B KINASE; INTRACELLULAR SIGNALING PEPTIDES AND PROTEINS; MULTIPROTEIN COMPLEXES; NF-KAPPA B; PEPTIDE HYDROLASES; PHOSPHORYLATION; PROTEIN BINDING; PROTEIN PROCESSING, POST-TRANSLATIONAL; SIGNAL TRANSDUCTION; UBIQUITINATION;

EID: 77955151535     PISSN: 15821838     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1582-4934.2009.00866.x     Document Type: Article

References (51)

1. Schmid JA, Birbach A. IkappaB kinase beta (IKKbeta/IKK2/IKBKB)-a key molecule in signaling to the transcription factor NF-kappaB. Cytokine Growth Factor Rev. 2008, 19:157-65.
2. Mercurio F, Zhu H, Murray BW. IKK-1 and IKK-2: cytokine-activated IkappaB kinases essential for NF- kappaB activation. Science. 1997, 278:860-6.
3. Zandi E, Rothwarf DM, Delhase M. The IkappaB kinase complex (IKK) contains two kinase subunits, IKKalpha and IKKbeta, necessary for IkappaB phosphorylation and NF-kappaB activation. Cell. 1997, 91:243-52.
4. Bonizzi G, Karin M. The two NF-kappaB activation pathways and their role in innate and adaptive immunity. Trends Immunol. 2004, 25:280-8.
5. Ghosh S, May MJ, Kopp EB. NF-kappa B and Rel proteins: evolutionarily conserved mediators of immune responses. Annu Rev Immunol. 1998, 16:225-60.
6. Karin M, Ben-Neriah Y. Phosphorylation meets ubiquitination: the control of NF-[kappa]B activity. Annu Rev Immunol. 2000, 18:621-63.
7. Karin M, Lin A. NF-kappaB at the crossroads of life and death. Nat Immunol. 2002, 3:221-7.
8. Yaron A, Hatzubai A, Davis M. Identification of the receptor component of the IkappaBalpha-ubiquitin ligase. Nature. 1998, 396:590-4.
9. Fuchs SY, Chen A, Xiong Y. HOS, a human homolog of Slimb, forms an SCF complex with Skp1 and Cullin1 and targets the phosphorylation-dependent degradation of IkappaB and beta-catenin. Oncogene. 1999, 18:2039-46.
10. Read MA, Brownell JE, Gladysheva TB. Nedd8 modification of cul-1 activates SCF(beta(TrCP))-dependent ubiquitination of IkappaBalpha. Mol Cell Biol. 2000, 20:2326-33.
11. Kawakami T, Chiba T, Suzuki T. NEDD8 recruits E2-ubiquitin to SCF E3 ligase. EMBO J. 2001, 20:4003-12.
12. Cope GA, Deshaies RJ. COP9 signalosome: a multifunctional regulator of SCF and other cullin-based ubiquitin ligases. Cell. 2003, 114:663-71.
13. Wei N, Deng XW. The COP9 signalosome. Annu Rev Cell Dev Biol. 2003, 19:261-86.
14. Schwechheimer C, Deng X. COP9 signalosome revisited: a novel mediator of protein degradation. Trends Cell Biol. 2001, 11:420-6.
15. Bech-Otschir D, Seeger M, Dubiel W. The COP9 signalosome: at the interface between signal transduction and ubiquitin-dependent proteolysis. J Cell Sci. 2002, 115:467-73.
16. Tomoda K, Kubota Y, Kato J. Degradation of the cyclin-dependent-kinase inhibitor p27Kip1 is instigated by Jab1. Nature. 1999, 398:160-5.
17. Lyapina S, Cope G, Shevchenko A. Promotion of NEDD-CUL1 conjugate cleavage by COP9 signalosome. Science. 2001, 292:1382-5.
18. Cope GA, Suh GS, Aravind L. Role of predicted metalloprotease motif of Jab1/Csn5 in cleavage of Nedd8 from Cul1. Science. 2002, 298:608-11.
19. Hetfeld BK, Helfrich A, Kapelari B. The zinc finger of the CSN-associated deubiquitinating enzyme USP15 is essential to rescue the E3 ligase Rbx1. Curr Biol. 2005, 15:1217-21.
20. Wee S, Geyer RK, Toda T. CSN facilitates Cullin-RING ubiquitin ligase function by counteracting autocatalytic adapter instability. Nat Cell Biol. 2005, 7:387-91.
21. Claret FX, Hibi M, Dhut S. A new group of conserved coactivators that increase the specificity of AP-1 transcription factors. Nature. 1996, 383:453-7.
22. Groisman R, Polanowska J, Kuraoka I. The ubiquitin ligase activity in the DDB2 and CSA complexes is differentially regulated by the COP9 signalosome in response to DNA damage. Cell. 2003, 113:357-67.
23. Fukumoto A, Tomoda K, Kubota M. Small Jab1-containing subcomplex is regulated in an anchorage- and cell cycle-dependent manner, which is abrogated by ras transformation. FEBS Lett. 2005, 579:1047-54.
24. Tomoda K, Kato JY, Tatsumi E. The Jab1/COP9 signalosome subcomplex is a downstream mediator of Bcr-Abl kinase activity and facilitates cell-cycle progression. Blood. 2005, 105:775-83.
25. Peng Z, Shen Y, Feng S. Evidence for a physical association of the COP9 signalosome, the proteasome, and specific SCF E3 ligases in vivo. Curr Biol 2003, 13:R504-5.
26. Huang X, Hetfeld BK, Seifert U. Consequences of COP9 signalosome and 26S proteasome interaction. FEBS J. 2005, 272:3909-17.
27. Seeger M, Kraft R, Ferrell K. A novel protein complex involved in signal transduction possessing similarities to 26S proteasome subunits. FASEB J. 1998, 12:469-78.
28. Bech-Otschir D, Kraft R, Huang X. COP9 signalosome-specific phosphorylation targets p53 to degradation by the ubiquitin system. EMBO J. 2001, 20:1630-9.
29. Uhle S, Medalia O, Waldron R. Protein kinase CK2 and protein kinase D are associated with the COP9 signalosome. EMBO J. 2003, 22:1302-12.
30. Sun Y, Wilson MP, Majerus PW. Inositol 1,3,4-trisphosphate 5/6-kinase associates with the COP9 signalosome by binding to CSN1. J Biol Chem. 2002, 277:45759-64.
31. Schweitzer K, Bozko PM, Dubiel W. CSN controls NF-kappaB by deubiquitinylation of IkappaBalpha. EMBO J. 2007, 26:1532-41.
32. Harari-Steinberg O, Cantera R, Denti S. COP9 signalosome subunit 5 (CSN5/Jab1) regulates the development of the Drosophila immune system: effects on Cactus, Dorsal and hematopoiesis. Genes Cells. 2007, 12:183-95.
33. Ebner K, Bandion A, Binder BR. GMCSF activates NF-kappaB via direct interaction of the GMCSF receptor with IkappaB kinase beta. Blood. 2003, 102:192-9.
34. Oitzinger W, Hofer-Warbinek R, Schmid JA. Adenovirus-mediated expression of a mutant IkappaB kinase 2 inhibits the response of endothelial cells to inflammatory stimuli. Blood. 2001, 97:1611-7.
35. Fu H, Reis N, Lee Y. Subunit interaction maps for the regulatory particle of the 26S proteasome and the COP9 signalosome. EMBO J. 2001, 20:7096-107.
36. Treier M, Staszewski LM, Bohmann D. Ubiquitin-dependent c-Jun degradation in vivo is mediated by the delta domain. Cell. 1994, 78:787-98.
37. Schmid JA, Birbach A, Hofer-Warbinek R. Dynamics of NF kappa B and Ikappa Balpha studied with green fluorescent protein (GFP) fusion proteins. Investigation of GFP-p65 binding to DNa by fluorescence resonance energy transfer. J Biol Chem. 2000, 275:17035-42.
38. Birbach A, Gold P, Binder BR. Signaling molecules of the NF-kappa B pathway shuttle constitutively between cytoplasm and nucleus. J Biol Chem. 2002, 277:10842-51.
39. Webster GA, Perkins ND. Transcriptional Cross Talk between NF-kappa B and p53. Mol Cell Biol. 1999, 19:3485-95.
40. Schmid JA, Sitte HH. Fluorescence resonance energy transfer in the study of cancer pathways. Curr Opin Oncol. 2003, 15:55-64.
41. Feige JN, Sage D, Wahli W. PixFRET, an ImageJ plug-in for FRET calculation that can accommodate variations in spectral bleed-throughs. Microsc Res Tech. 2005, 68:51-8.
42. Muratani M, Kung C, Shokat KM. The F box protein Dsg1/Mdm30 is a transcriptional coactivator that stimulates Gal4 turnover and cotranscriptional mRNA processing. Cell. 2005, 120:887-99.
43. Hong X, Xu L, Li X. CSN3 interacts with IKKgamma and inhibits TNF- but not IL-1-induced NF-kappaB activation. FEBS Lett. 2001, 499:133-6.
44. Perkins ND. Integrating cell-signalling pathways with NF-kappaB and IKK function. Nat Rev Mol Cell Biol. 2007, 8:49-62.
45. Wolf DA, Zhou C, Wee S. The COP9 signalosome: an assembly and maintenance platform for cullin ubiquitin ligases? Nat Cell Biol. 2003, 5:1029-33.
46. Panattoni M, Sanvito F, Basso V. Targeted inactivation of the COP9 signalosome impairs multiple stages of T cell development. J Exp Med. 2008, 205:465-77.
47. Wang J, Li C, Liu Y. JAB1 determines the response of rheumatoid arthritis synovial fibroblasts to tumor necrosis factor-alpha. Am J Pathol. 2006, 169:889-902.
48. Kleemann R, Hausser A, Geiger G. Intracellular action of the cytokine MIF to modulate AP-1 activity and the cell cycle through Jab1. Nature. 2000, 408:211-6.
49. Burger-Kentischer A, Goebel H, Seiler R. Expression of macrophage migration inhibitory factor in different stages of human atherosclerosis. Circulation. 2002, 105:1561-6.
50. Oono K, Yoneda T, Manabe T. JAB1 participates in unfolded protein responses by association and dissociation with IRE1. Neurochemistry International. 2004, 45:765-72.
51. Richardson KS, Zundel W. The emerging role of the COP9 signalosome in cancer. Mol Cancer Res. 2005, 3:645-53.